Olympus unveils Cutting Edge microdissection technology
Olympus introduces its CellCut laser microdissection system for the life sciences industry, which eliminates any direct specimen contact ensuring totally contamination-free samples.
Archives for September 21, 2005
Celsis, BioVentures team up on contamination detection
Celsis International has signed a collaboration with BioVentures to develop a microarray-based microbiological testing system to detect contamination in pharmaceutical, biotechnology and other process industries.
Alliance aims at foam-based treatment for scabies
Foamix, an Israeli company specialising in the development of topical drug delivery systems, has entered into an agreement with drugmaker Stiefel Laboratories for the development of a foam-based treatment for scabies.
Web-based pedigree system launched in US
PD-Rx Pharmaceuticals says it has completed the infrastructure of an online, web-based pharmaceutical tracking system - called the Pedigree Security Network - to help combat drug counterfeiting.
PerkinElmer and Invitrogen in ion channel deal
PerkinElmer and Invitrogen enter into a strategic agreement to streamline drug development in which the collaboration will combine PerkinElmer's technology for ion channel drug discovery and Invitrogen's voltage sensor probe reagents.
Queen's novel HIV research to address HIV pandemic
Researchers have helped pioneer a novel approach to the development and delivery of an HIV/AIDS vaccine, which involves a female-controlled vaginal HIV vaccine. The novel method is to be tried in order to break the infection cycle and its appalling...
Cell culture sector boosts biopharm fortunes
According to a new report, the biopharmaceutical market is predicted to increase from $1.4 billion (€1.14 billion) in 2003 to $2.6 billion in 2006. The market was dwarfed by the pharmaceutical industry 20 years ago but continues to outgrow its rival...
Restricted access barrier systems defined
The International Society of Pharmaceutical Engineers (ISPE) has developed a definition of restricted access barrier systems, in collaboration with the US Food and Drug Administration, in order to clear up confusion in the pharmaceutical industry...